Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2005

Open Access 01-12-2005 | Debate

Systems validation: application to statistical programs

Author: Rickey E Carter

Published in: BMC Medical Research Methodology | Issue 1/2005

Login to get access

Abstract

Background

In 2003, the United States Food and Drug Administration (FDA) released a guidance document on the scope of "Part 11" enforcement. In this guidance document, the FDA indicates an expectation of a risk-based approach to determining which systems should undergo validation. Since statistical programs manage and manipulate raw data, their implementation should be critically reviewed to determine whether or not they should undergo validation. However, the concepts of validation are not often discussed in biostatistics curriculum.

Discussion

This paper summarizes a "Plan, Do, Say" approach to validation that can be incorporated into statistical training so that biostatisticians can understand and implement validation principles in their research.

Summary

Validation is a process that requires dedicated attention. The process of validation can be easily understood in the context of the scientific method.
Literature
1.
go back to reference FDA: 21 CFR Part 11 Electronic Records; Electronic Signatures – Glossary of Terms. 2001 FDA: 21 CFR Part 11 Electronic Records; Electronic Signatures – Glossary of Terms. 2001
2.
go back to reference Stokes T: The survive and thrive guide to computer validation. 1998, Buffalo Grove, Il: Interpharm Press Stokes T: The survive and thrive guide to computer validation. 1998, Buffalo Grove, Il: Interpharm Press
3.
go back to reference Stokes T, Branning R, Chapman K, Hambloch H, Trill A, Goldstein S: Good computer validation practices: common sense implementation. 1994, Taylor & Francis Stokes T, Branning R, Chapman K, Hambloch H, Trill A, Goldstein S: Good computer validation practices: common sense implementation. 1994, Taylor & Francis
4.
go back to reference Moher D, Schulz KF, Altman D: The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001, 357 (9263): 1191-1194. 10.1016/S0140-6736(00)04337-3.CrossRefPubMed Moher D, Schulz KF, Altman D: The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001, 357 (9263): 1191-1194. 10.1016/S0140-6736(00)04337-3.CrossRefPubMed
5.
go back to reference FDA: Draft guidance for industry: 21 CFR Part 11 electronic records; electronic signatures – Validation. 2001 FDA: Draft guidance for industry: 21 CFR Part 11 electronic records; electronic signatures – Validation. 2001
6.
go back to reference The SAS System for Windows (Version 8). Computer software. 1999 The SAS System for Windows (Version 8). Computer software. 1999
Metadata
Title
Systems validation: application to statistical programs
Author
Rickey E Carter
Publication date
01-12-2005
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2005
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/1471-2288-5-3

Other articles of this Issue 1/2005

BMC Medical Research Methodology 1/2005 Go to the issue